Scientific publications
Journal Articles:
- Bluhmki T, Schmoor C, Dobler D, Pauly M, Finke J, Schumacher M, Beyersmann J: A wild bootstrap approach for the Aalen-Johansen estimator. Biometrics, 2018; 74: 977-985. : https://doi.org/10.1111/biom.12861
- Brinster R, Köttgen A, Tayo BO, Schumacher M, Sekula P, CKDGen Consortium: Control procedures and estimators of the false discovery rate and their application in low-dimensional settings: an empirical investigation. Bmc Bioinformatics, 2018; 19 (online): 78-78. : https://doi.org/10.1186/s12859-018-2081-x
- Grigioni F, Clavel MA, Vanoverschelde JL, Tribouilloy C, Pizarro R, Huebner M, Avierinos JF, Barbieri A, Suri R, Pasquet A, Rusinaru D, Gargiulo GD, Oberti P, Théron A, Bursi F, Michelena H, Lazam S, Szymanski C, Nkomo VT, Schumacher M, Bacchi-Reggiani L, Enriquez-Sarano M, MIDA Investigators: The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation. Eur Heart J, 2018; 39: 1281-1291. : https://doi.org/10.1093/eurheartj/ehx465
- Hazard D, Schumacher M, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Wolkewitz M: Improving nested case-control studies to conduct a full competing-risks analysis for nosocomial infections. Infect Cont Hosp Ep, 2018; 39 (10): 1196-1201. : https://doi.org/10.1017/ice.2018.186
- Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, Hantel S, Bluhmki E, Lachin JM: How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care, 2018; 41: 356-363. : https://doi.org/10.2337/dc17-1096
- Jenny B, Beyersmann J, Schumacher M: A simulation approach for power calculation in large cohort studies based on multistate models. Biometrical J, 2018; 60: 671-686. : https://doi.org/10.1002/bimj.201700074
- Poguntke I, Schumacher M, Beyersmann J, Wolkewitz M, On Behalf Of Combacte-Magnet Consortium MW: Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes. Bmc Med Res Methodol, 2018; 18 (online): 79. : https://doi.org/10.1186/s12874-018-0535-5
- Rahman S, von Cube M, Schumacher M, Wolkewitz M: Bias due to censoring of deaths when calculating extra length of stay for patients acquiring a hospital infection. Bmc Med Res Methodol, 2018; 18 (online): 49. : https://doi.org/10.1186/s12874-018-0500-3
- Sommer H, Bluhmki T, Beyersmann J, Schumacher M, COMBACTE-NET, COMBACTE-MAGNET consortium.: Assessing non-inferiority in treatment trials regarding severe infectious diseases: An extension to the entire follow-up period using a cure-death multistate model. Antimicrob Agents Ch, 2018; 62 (online): e01691-17. : https://doi.org/10.1128/AAC.01691-17
- Sommer H, Timsit JF, von Cube M, Schumacher M, Darmon M, Schwebel C, Ruckly S, Wolkewitz M, COMBACTE-MAGNET Consortium.: The Impact of Early Adequate Treatment on Extubation and Discharge Alive of Patients With Pseudomonas aeruginosa-Related Ventilator-Associated Pneumonia. Crit Care Med, 2018; 46: 1643-1648. : https://doi.org/10.1097/CCM.0000000000003305
- Wolkewitz M, Mandel M, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Schumacher M.: Methodological challenges in using point-prevalence versus cohort data in risk factor analyses of nosocomial infections. Ann Epidemiol, 2018; 28: 475-480. : https://doi.org/10.1016/j.annepidem.2018.03.017
|
